Aarti Pharmalabs Management
Management criteria checks 1/4
Aarti Pharmalabs' CEO is Hetal Gala, appointed in Oct 2022, has a tenure of 2.33 years. total yearly compensation is ₹86.90M, comprised of 11.4% salary and 88.6% bonuses, including company stock and options. directly owns 2.89% of the company’s shares, worth ₹1.53B. The average tenure of the management team and the board of directors is 2.3 years and 2.3 years respectively.
Key information
Hetal Gala
Chief executive officer
₹86.9m
Total compensation
| CEO salary percentage | 11.4% |
| CEO tenure | 2.3yrs |
| CEO ownership | 2.9% |
| Management average tenure | 2.3yrs |
| Board average tenure | 2.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹2b |
| Jun 30 2024 | n/a | n/a | ₹2b |
| Mar 31 2024 | ₹87m | ₹10m | ₹2b |
Compensation vs Market: Hetal's total compensation ($USD1.00M) is above average for companies of similar size in the Indian market ($USD357.71K).
Compensation vs Earnings: Insufficient data to compare Hetal's compensation with company performance.
CEO
Hetal Gala (49 yo)
2.3yrs
Tenure
₹86,900,000
Compensation
Smt. Hetal Gogri Gala serves as Non-Executive Director at Aarti Industries Ltd. since October 17, 2022. She serves as Vice Chairperson and Managing Director of Aarti Pharmalabs Limited from October 17, 202...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Vice Chairperson & MD | 2.3yrs | ₹86.90m | 2.89% ₹ 1.5b | |
| MD & Director | no data | ₹15.00m | no data | |
| Chief Financial Officer | 2.3yrs | no data | no data | |
| Head of Operations & Manufacturing | no data | no data | no data | |
| Senior General Manager of HR & Admin | no data | no data | no data | |
| Company Secretary & Compliance Officer | less than a year | no data | no data | |
| President of R&D | no data | no data | no data | |
| Head of Business Development & Direct Procurement | no data | no data | no data | |
| Head of API Export Regulated and R&D Management | no data | no data | no data |
2.3yrs
Average Tenure
Experienced Management: 543748's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Vice Chairperson & MD | 3.5yrs | ₹86.90m | 2.89% ₹ 1.5b | |
| MD & Director | 3.5yrs | ₹15.00m | no data | |
| Chairperson | 3.5yrs | ₹190.00k | 4.23% ₹ 2.2b | |
| Non-Executive Director | 3.5yrs | ₹190.00k | 1.91% ₹ 1.0b | |
| Chairman Emeritus | no data | no data | 0.17% ₹ 90.9m | |
| Non-Executive Director | 2.3yrs | ₹170.00k | 0.44% ₹ 233.6m | |
| Independent Director | 2.3yrs | ₹260.00k | no data | |
| Independent Director | 2.3yrs | ₹233.00k | no data | |
| Non-Executive Director | less than a year | no data | 1.24% ₹ 656.1m | |
| Independent Director | 2.3yrs | ₹170.00k | no data | |
| Independent Director | 2.3yrs | ₹250.00k | no data | |
| Independent Director | 2.3yrs | ₹223.00k | no data |
2.3yrs
Average Tenure
61yo
Average Age
Experienced Board: 543748's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/02 08:00 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Aarti Pharmalabs Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|